<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en"><id>http://publicationslist.org/data/dartaemulina/atom.xml</id><title>Dārta Elizabete Senkāne's Publications List</title>
<link rel="self" type="application/atom+xml" href="//publicationslist.org/data/dartaemulina/atom.xml"/><link rel="alternate" type="text/html" href="//publicationslist.org/dartaemulina"/><author><name>Dārta Elizabete Senkāne</name><uri>//publicationslist.org/dartaemulina</uri></author><icon>$basepathfavicon.ico</icon><subtitle>Recent additions to Dārta Elizabete Senkāne's PublicationsList.org page</subtitle><logo>//publicationslist.org/publications.png</logo><updated>2026-04-20T09:15:47Z</updated>

<entry>
<id>//publicationslist.org/dartaemulina/refid2</id>
<updated>2026-04-20T09:14:13Z</updated>
<link rel='alternate' type='text/html' href='//publicationslist.org/dartaemulina#refid2'/>
<title type='html'>The Impact of  and  Variants on Periodontitis Risk in Phenylketonuria and Type 1 Diabetes Mellitus Patients in a Latvian Population.</title>
<summary type='html'>Periodontitis is a multifactorial disease that affects approximately 11% of the global population. The objective of this study was to examine whether, among individuals with phenylketonuria and type 1 diabetes mellitus, those with the  and/or  genetic variants exhibit a higher periodontitis risk compared to healthy controls.&lt;br/&gt;&lt;br/&gt;Darta Elizabete Emulina, Iveta Abola, Anda Brinkmane, Aleksejs Isakovs, Ingus Skadins, Georgijs Moisejevs, Linda Gailite, Madara Auzenbaha (2024)  &lt;i&gt;Diagnostics (Basel, Switzerland)&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 14: 2 &lt;br/&gt;</summary>
</entry>
<entry>
<id>//publicationslist.org/dartaemulina/refid3</id>
<updated>2026-04-20T09:14:50Z</updated>
<link rel='alternate' type='text/html' href='//publicationslist.org/dartaemulina#refid3'/>
<title type='html'>Oral Microbiome Traits of Type 1 Diabetes and Phenylketonuria Patients in Latvia.</title>
<summary type='html'>Some metabolic disorder treatments require patients to follow a specific diet or to consume supplements that, over time, can lead to oral microbiome alterations. Well-known disorders requiring such treatment are phenylketonuria (PKU), an inborn error of amino acid metabolism, and type 1 diabetes (T1D), a metabolic disorder that requires a specific diet regimen. Therefore, the aim of this study was...&lt;br/&gt;&lt;br/&gt;Iveta Abola, Dita Gudra, Maija Ustinova, Davids Fridmanis, Darta Elizabete Emulina, Ingus Skadins, Anda Brinkmane, Una Lauga-Tunina, Linda Gailite, Madara Auzenbaha (2023)  &lt;i&gt;Microorganisms&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 11: 6 &lt;br/&gt;</summary>
</entry>
<entry>
<id>//publicationslist.org/dartaemulina/refid4</id>
<updated>2026-04-20T09:15:14Z</updated>
<link rel='alternate' type='text/html' href='//publicationslist.org/dartaemulina#refid4'/>
<title type='html'>Dental Status and Periodontal Health of Patients with Phenylketonuria in Latvia.</title>
<summary type='html'>Phenylketonuria (PKU) is an autosomal recessive inherited disorder of phenylalanine metabolism resulting from a deficiency of phenylalanine hydroxylase. The aim of this study was to evaluate the dental status and periodontal health of PKU patients in Latvia.&lt;br/&gt;&lt;br/&gt;Iveta Ābola, Dārta Elizabete Emuliņa, Ingus Skadiņš, Anda Brinkmane, Linda Gailīte, Madara Auzenbaha (2022)  &lt;i&gt;Acta stomatologica Croatica&lt;/i&gt; &lt;i&gt;&lt;/i&gt; &lt;i&gt;&lt;/i&gt; 56: 2 109-119&lt;br/&gt;</summary>
</entry>
</feed>
